Zhongchao(US:ZCMD)2026-04-03 20:00Financial Performance - For the year ended December 31, 2025, total revenues reached $11,374,996, while gross profit was $5,121,541[35]. - The net loss for the year ended December 31, 2025, was $5,814,867, compared to a net loss of $273,413 for the year ended December 31, 2024[35]. - For the fiscal year ended December 31, 2023, the company's total revenues were $19,433,945, a decrease from $15,864,773 in 2024 and $11,374,996 in 2025[45]. - The net loss for the year ended December 31, 2023, was $(11,307,239), compared to $(273,413) in 2024 and $(5,814,867) in 2025, indicating a significant increase in losses[45]. - The company reported a gross profit of $8,512,192 for the year ended December 31, 2023, after costs of revenue amounting to $(10,921,753)[36]. - In 2025, the company's revenues were $11,374,996, a decrease from $15,864,773 in 2024 and $19,433,945 in 2023, indicating a downward trend in financial performance[60]. - The company reported net losses of $(5,814,867) in 2025, $(273,413) in 2024, and $(11,307,239) in 2023, highlighting ongoing financial challenges[60]. Cash Transfers and Dividends - Zhongchao Cayman made cash transfers of $3.4 million, $4.4 million, and $0.1 million to Zhongchao USA for the years ended December 31, 2025, 2024, and 2023 respectively[25]. - No dividends or distributions were made to Zhongchao Cayman or U.S. investors for the years ended December 31, 2025, 2024, and 2023[25]. - The company intends to reinvest future earnings to finance the expansion of the PRC operating entities and does not anticipate paying cash dividends in the foreseeable future[26]. - The PRC government imposes a 10% withholding tax on dividends payable to non-PRC-resident enterprises, which may be reduced to 5% under certain conditions[154]. - The company has not applied for a tax resident certificate from the Hong Kong tax authority, which may affect its ability to enjoy a preferential withholding tax rate of 5%[32]. Regulatory Environment - PRC regulations require that dividends from indirect PRC subsidiaries can only be paid out of accumulated profits, and at least 10% of after-tax profits must be set aside for statutory reserves[28]. - The PRC government imposes controls on the conversion of RMB into foreign currencies, which may hinder the ability to remit dividends[29]. - The company is currently not required to obtain additional permissions from PRC authorities for its operations, but future regulatory changes could impose new requirements[24]. - The Trial Administrative Measures effective March 31, 2023, require domestic companies seeking to list overseas to fulfill filing procedures with the CSRC, which may impact future offerings[22]. - The PRC operating entities must comply with the Interim Administrative Measures on Overseas Securities Offering and Listing, which require filing procedures with the CSRC within three business days after each offering[147]. Operational Challenges - The company may face challenges in obtaining necessary government approvals for capital contributions or foreign loans to its PRC subsidiaries, which could adversely affect liquidity[32]. - The company faces intense competition in the healthcare information, education, and training services market, which is expected to persist and intensify[50]. - The company relies on a small number of major customers for a significant portion of its revenues, posing a risk to its financial stability[42]. - The company is actively seeking to recruit and retain IT talents and management personnel to support its growth and operational needs[47]. - The company intends to continue expanding its operations to pursue existing and potential market opportunities, despite facing significant management and operational challenges[48]. Risks and Liabilities - The VIE structure poses unique risks, including potential changes in PRC laws that could affect the company's operations and share value[21]. - The company may face significant legal liabilities if it fails to comply with evolving PRC data protection laws[188]. - The PRC operating entities may face costly intellectual property infringement claims, which could divert management's attention and require substantial damages or changes to their technology[77]. - The company currently lacks business interruption insurance, which could expose it to significant losses from unexpected events affecting its data facilities[70]. - The company may be subject to negative publicity and legal exposure due to security breaches or unauthorized access to data, which could harm its reputation and business[207]. Internal Controls and Compliance - The company has identified material weaknesses in its internal control over financial reporting, which could lead to inaccurate financial results or fraud[90]. - To address these weaknesses, the company has hired an experienced consultant and is providing ongoing training in U.S. GAAP to its personnel[92]. - The effectiveness of internal controls may vary over time due to inherent limitations, including human error and changes in conditions[93]. - The company is currently facing material weaknesses in internal controls over financial reporting, which could lead to inaccurate financial results and loss of investor confidence[94]. User Base and Market Position - The company has over 194,700 registered users and a database of approximately 111,070 healthcare experts, indicating a strong user base[44]. - In 2023, 52.5% of the company's revenues were derived from services and products provided to pharmaceutical enterprises, which decreased to 35.2% in 2024 and further to 32.5% in 2025, indicating a significant reliance on this sector[49]. - The company has expanded operations significantly, resulting in increased headcount and fixed overhead costs, which may impact profitability if resource utilization levels are not maintained[66]. Cybersecurity and Data Protection - The company has implemented security measures to protect customer and company data, but acknowledges potential vulnerabilities to cyber threats[205]. - The company may face uncertainties regarding compliance with evolving PRC cybersecurity laws and regulations, which could result in fines or operational disruptions[204]. - The latest Cybersecurity Review Measures require online platform operators with more than one million users' individual information to undergo a cybersecurity review before listing abroad[198]. - The PRC Data Security Law imposes obligations on entities regarding data security and privacy, with a national security review procedure for data activities that may affect national security[203]. Corporate Governance - The dual class structure of ordinary shares concentrates voting control with the CEO, limiting shareholder influence over corporate matters[114]. - The Company is classified as a "controlled company" under NASDAQ rules, which may exempt it from certain corporate governance requirements, potentially affecting shareholder protections[121]. - The CEO, Mr. Weiguang Yang, controls a majority of the voting power with 68,750 Class A and 624,972 Class B ordinary shares, allowing him to influence key decisions including mergers and director elections[120].